SCHEMBL702269

SCHEMBL702269

c1cncc(C2(CN3CCCC3)CCNCC2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 5/20 0.44
CHRNA4 P43681 5/20 0.44
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C19 P33261 1/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
SLC6A3 Q01959 2/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HSD11B1 P28845 3/20 0.38
HPGD P15428 1/20 0.37
P2RX7 Q99572 1/20 0.36
CHRNA1 P02708 1/20 0.36
CHRNG P07510 1/20 0.36
CHRNB1 P11230 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA7 P36544 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL701862 0.86 CHRNB2 (0.44) CHRNB2CHRNA4ALDH1A1CYP3A4CYP2D6
SCHEMBL10246542 0.84 CHRNB2 (0.42) CHRNB2CHRNA4ALDH1A1CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL700263 0.83 CCR1 (0.41) CHRNB2CHRNA4ALDH1A1CYP3A4CYP2D6
SCHEMBL3441563 0.81 CHRNB2 (0.48) CHRNB2CHRNA4SLC6A4CCR1
SCHEMBL2792094 0.81 TACR1 (0.48) ALDH1A1CYP2D6CYP2C19SLC6A2SLC6A4
SCHEMBL28285171 0.78 MAOA (0.46) CHRNB2CHRNA4SLC6A4SLC6A3MEN1
SCHEMBL16915617 0.76 HTT (0.40) CYP3A4MEN1KMT2AHSD11B1HPGD
SCHEMBL2110717 0.76 CHRNB2 (0.50) CHRNB2CHRNA4ALDH1A1CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL2333516 0.75 CHRNB2 (0.49) CHRNB2CHRNA4ALDH1A1CYP3A4CYP2D6
SCHEMBL4292893 0.75 CHRNB2 (0.49) CHRNB2CHRNA4CYP3A4CYP2D6MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8124624-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
US-8124624-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
US-8124624-B2 Substituted sulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-28 US disclosed
EP-2262791-A2 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-12-22 EP disclosed
US-20090264407-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
US-20090264407-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
US-20090264407-A1 Substituted Sulfonamide Compounds GRUENENTHAL GMBH (DE) 2009-10-22 US disclosed
WO-2009124734-A2 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-10-15 WO disclosed
WO-2009124734-A2 SUBSTITUTED SULFONAMIDE DERIVATIVES Grünenthal GmbH (DE) 2009-10-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264407-A1 Substituted Sulfonamide Compounds CNR1, SUCNR1, OPRL1 CHRNB2 888/4885CHRNA4 977/4885ALDH1A1 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.